Novel antimicrobial lipopeptides with long in vivo half-lives
- 1 February 2010
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (2) , 182-185
- https://doi.org/10.1016/j.ijantimicag.2009.10.013
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- N-Methylation of Peptides: A New Perspective in Medicinal ChemistryAccounts of Chemical Research, 2008
- Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentNew England Journal of Medicine, 2006
- Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United StatesAnnals of Clinical Microbiology and Antimicrobials, 2006
- The Burden of Staphylococcus aureus Infections on Hospitals in the United StatesArchives of internal medicine (1960), 2005
- Allometric scaling of pharmacokinetic parameters in drug discovery: Can human CL, Vss and t1/2 be predicted fromin-vivo rat data?European Journal of Drug Metabolism and Pharmacokinetics, 2004
- In Vivo Pharmacodynamic Activity of DaptomycinAntimicrobial Agents and Chemotherapy, 2004
- Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2003